Context Therapeutics Inc. (CNTX)
USD 1.22
(-5.43%)
USD 1.22
(-5.43%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -21.04 Million | -13.54 Million | -8.79 Million | -1.03 Million | -2.83 Million |
| Net Income | -23.96 Million | -14.83 Million | -10.45 Million | 6.64 Million | -6.38 Million |
| Depreciation & Amortization | 12.04 Thousand | 9268.00 | - | - | - |
| Deferred income taxes | -24.32 Million | - | - | - | - |
| Stock-based compensation | 1.07 Million | 976.44 Thousand | 511.07 Thousand | 219.24 Thousand | 775.25 Thousand |
| Change in working capital | 1.77 Million | -277.52 Thousand | -2.22 Million | 1.31 Million | 561.79 Thousand |
| Other non-cash items | 24.37 Million | 578.52 Thousand | 3.37 Million | -9.21 Million | 2.21 Million |
| Investing Cash Flow | - | -536.83 Thousand | -250 Thousand | - | - |
| Investments in PPE | - | -536.83 Thousand | -250 Thousand | - | - |
| Acquisitions | - | - | - | - | - |
| Investment purchases | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | - | -500.00 | -250 Thousand | - | - |
| Financing Cash Flow | - | -102.07 Thousand | 58.39 Million | 1.14 Million | 1.95 Million |
| Debt repayment | - | - | - | -149.05 Thousand | -1.95 Million |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | 309.39 Thousand | 53.41 Million | 1 Million | - |
| Other Financing Activities | - | -411.46 Thousand | 4.98 Million | 298.1 Thousand | 3.91 Million |
| Accounts receivables | - | - | - | - | - |
| Accounts payables | 1.44 Million | -787.89 Thousand | -866 Thousand | 556.27 Thousand | 505.41 Thousand |
| Inventory | - | - | - | - | - |
| Other working capital | 329.03 Thousand | 510.36 Thousand | -1.35 Million | 762.03 Thousand | 56.38 Thousand |
| Cash at beginning of period | 35.49 Million | 49.68 Million | 341.03 Thousand | 226.6 Thousand | 1.1 Million |
| Cash at end of period | 14.44 Million | 35.49 Million | 49.68 Million | 341.03 Thousand | 226.6 Thousand |
| Capital Expenditure | - | -536.83 Thousand | -250 Thousand | - | - |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | -21.04 Million | -14.18 Million | 49.34 Million | 114.43 Thousand | -878.69 Thousand |
| Free Cash Flow | -21.04 Million | -14.08 Million | -9.04 Million | -1.03 Million | -2.83 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.25 Million | -3.66 Million | -6.76 Million | -23.96 Million | -5.87 Million | -5.01 Million |
| Depreciation & Amortization | 2568.00 | 2568.00 | 2568.00 | 12.04 Thousand | 3089.00 | 3194.00 |
| Deferred income taxes | - | - | 294.02 Thousand | -24.32 Million | - | - |
| Stock-based compensation | 157.03 Thousand | 240 Thousand | 256.05 Thousand | 1.07 Million | 254.94 Thousand | 283.1 Thousand |
| Change in working capital | -1.26 Million | -935.39 Thousand | -715.9 Thousand | 1.77 Million | 2.14 Million | 71.54 Thousand |
| Other non-cash items | 1.64 Million | 582.79 Thousand | -294.02 Thousand | 24.37 Million | 7522.00 | 22.37 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | 4.00 | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 94.8 Million | - | - | - | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 94.8 Million | - | - | - | - | - |
| Other Financing Activities | 94.8 Million | - | - | - | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -1.47 Million | -337.65 Thousand | 555.2 Thousand | 1.44 Million | 636.95 Thousand | -19.4 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 217.63 Thousand | -597.74 Thousand | -1.27 Million | 329.03 Thousand | 1.51 Million | 90.95 Thousand |
| Cash at beginning of period | 10.08 Million | 14.44 Million | 21.67 Million | 35.49 Million | 25.13 Million | 29.76 Million |
| Cash at end of period | 101.53 Million | 10.08 Million | 14.44 Million | 14.44 Million | 21.67 Million | 25.13 Million |
| Capital Expenditure | 4.00 | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 91.44 Million | -4.36 Million | -7.22 Million | -21.04 Million | -3.46 Million | -4.63 Million |
| Free Cash Flow | -3.35 Million | -4.36 Million | -7.22 Million | -21.04 Million | -3.46 Million | -4.63 Million |
002519
7991
002637
NIITLTD
000887
9587